查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602357

痤瘡治療藥物市場：按痤瘡類型、藥物類別、藥物類型、給藥途徑分類 - 全球預測 2025-2030

Acne Drugs Market by Acne Type (Comedonal, Cystic, Inflammatory), Drug Class (Antibiotics, Combination Drugs, Hormonal Agents), Drug Type, Route of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年痤瘡治療市場價值為59.6億美元，預計到2024年將達到63.2億美元，複合年成長率為6.23%，預計到2030年將達到91億美元。

痤瘡治療市場的範圍包括開發用於治療痤瘡的藥物，痤瘡是一種影響全球數百萬人的常見皮膚病。這個市場包括非處方藥和處方藥，如類類視色素A、抗生素和荷爾蒙治療。對痤瘡藥物的需求源於美學和健康問題，以解決身體不適和心理影響，如低自尊和社交焦慮。應用範圍從外用乳膏到內服藥物，用於治療不同程度的痤瘡嚴重程度。最終用途包括私人消費者、皮膚科診所和醫院。影響生長的因素包括皮膚健康意識的提高、皮膚病學研究的進步以及痤瘡盛行率的上升，尤其是在青少年和成年人中。現代商機，例如對個人化醫療日益成長的興趣以及向天然和有機產品的轉變，正在為企業指明創新之路。公司可以透過投資個人化治療解決方案的研發和擴大有機產品線來利用這些優勢。然而，市場面臨著限制和挑戰，例如嚴格的監管監督、潛在的藥物副作用以及來自雷射療法等替代療法的競爭。此外，圍繞痤瘡治療藥物的功效和安全性問題也是一個主要障礙。具有巨大潛力的創新領域包括基於生物技術的解決方案、微生物友善產品以及用於個人化治療計劃的人工智慧主導的診斷工具。該市場的特點是技術進步迅速，競爭公司之間競爭激烈。公司應專注於與皮膚科醫生合作並投資消費者教育，以克服市場挑戰並利用新趨勢。此外，透過確保進行臨床試驗並保持產品功效的透明度，公司可以獲得消費者的信任並擴大市場。

主要市場統計
基準年[2023] 59.6億美元
預測年份 [2024] 63.2億美元
預測年份 [2030] 91億美元
複合年成長率（%） 6.23%

市場動態：揭示快速發展的痤瘡治療市場的關鍵市場洞察

供需的動態交互作用正在改變痤瘡治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球皮膚相關疾病的增加
    • 提高皮膚健康意識並專注於個人化治療
    • 電子商務平台上痤瘡治療藥物的供應不斷增加
  • 市場限制因素
    • 護膚藥物替代品增加
  • 市場機會
    • 介紹改良和增強的痤瘡治療方法
    • 聯合治療的需求不斷成長
  • 市場挑戰
    • 化妝品核准法規嚴格、流程複雜

波特的五力：駕馭痤瘡治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解痤瘡治療市場的外部影響

外部宏觀環境因素在塑造痤瘡治療藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解痤瘡治療市場的競爭格局

對痤瘡治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 痤瘡治療藥物市場供應商定位矩陣績效評估

FPNV定位矩陣是評估痤瘡治療藥物市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃痤瘡治療藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對痤瘡治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球皮膚相關疾病的發生率增加
      • 人們對皮膚健康的認知不斷提高以及個人化治療的趨勢
      • 提高電子商務平台上痤瘡治療的可用性
    • 抑制因素
      • 護膚藥物有很多替代品。
    • 機會
      • 介紹改良和增強的痤瘡治療方法
      • 聯合治療的需求不斷成長
    • 任務
      • 化妝品藥品核准監管嚴格、流程複雜
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按痤瘡類型分類的痤瘡治療藥物市場

  • 粉刺性的
  • 囊狀的
  • 發炎的
  • 手術後/傷口

第7章按藥物類別分類的痤瘡治療藥物市場

  • 抗生素
  • 伴隨藥物
  • 荷爾蒙藥物
  • 類視色素A

第 8 章：按藥物類型分類的痤瘡治療市場

  • 非處方藥
  • 處方藥

第9章痤瘡治療藥物市場：依給藥途徑

  • 可注射的
  • 口服
  • 話題

第10章美洲痤瘡治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區痤瘡治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章：歐洲、中東和非洲的痤瘡治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Almirall, SA
  • Amgen, Inc.
  • Apotex Inc.
  • Arctic Therapeutics
  • Bausch Health Companies Inc.
  • Bayer AG
  • BioPharmX, Inc.
  • Cipher Pharmaceuticals Inc.
  • Daiichi Sankyo Company, Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Galderma SA
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson Services, Inc.
  • Mayne Pharma Group Limited
  • Midas Pharma GmbH
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Skinvisible Pharmaceuticals, Inc.
  • Stiefel Laboratories, Inc. by GSK Group
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-434CCDA051B4

The Acne Drugs Market was valued at USD 5.96 billion in 2023, expected to reach USD 6.32 billion in 2024, and is projected to grow at a CAGR of 6.23%, to USD 9.10 billion by 2030.

The scope of the acne drugs market encompasses pharmaceutical products developed to treat acne, a common dermatological condition affecting millions globally. This market includes over-the-counter solutions and prescription medications such as retinoids, antibiotics, and hormonal treatments. The necessity of acne drugs arises from both cosmetic and health considerations, addressing physical discomfort and psychological impacts, such as diminished self-esteem and social anxiety. Applications extend from topical creams to oral medications, catering to various severity levels of acne. End-use includes individual consumers, dermatology clinics, and hospitals. Influencing growth factors include increasing awareness of skin health, advancements in dermatological research, and the rising prevalence of acne, particularly among adolescents and adults. The latest opportunities, such as the growing interest in personalized medicine and the shift towards natural and organic products, present avenues for businesses to innovate. Companies can capitalize on these by investing in R&D for personalized treatment solutions and expanding organic product lines. However, the market faces limitations and challenges like stringent regulatory scrutiny, potential side effects of drugs, and high competition from alternative treatments such as laser therapy. Moreover, the efficacy and safety concerns surrounding acne medications pose significant hurdles. Innovation areas with great potential include biotechnology-based solutions, microbiome-friendly products, and artificial intelligence-driven diagnostic tools for personalized treatment plans. The market is characterized by rapid technological advancements and intense competitive rivalry. Businesses should focus on collaboration with dermatologists and investing in consumer education to overcome market challenges and leverage emerging trends. Ensuring robust clinical trials and maintaining transparency in product efficacy can also instill consumer trust and expand market reach.

KEY MARKET STATISTICS
Base Year [2023] USD 5.96 billion
Estimated Year [2024] USD 6.32 billion
Forecast Year [2030] USD 9.10 billion
CAGR (%) 6.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acne Drugs Market

The Acne Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of skin-related diseases in individuals worldwide
    • Growing awareness regarding skin health and inclination toward specific personalized treatments
    • Increasing availability of acne drugs on eCommerce platforms
  • Market Restraints
    • Availability of numerous alternatives for skin care drugs
  • Market Opportunities
    • Introduction of improved and enhanced acne drugs
    • Emerging demand for combination therapy
  • Market Challenges
    • Stringent regulations and complicated processes in the approval of cosmetic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Acne Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acne Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acne Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acne Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acne Drugs Market

A detailed market share analysis in the Acne Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acne Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acne Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acne Drugs Market

A strategic analysis of the Acne Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acne Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almirall, S.A., Amgen, Inc., Apotex Inc., Arctic Therapeutics, Bausch Health Companies Inc., Bayer AG, BioPharmX, Inc., Cipher Pharmaceuticals Inc., Daiichi Sankyo Company, Ltd., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Galderma S.A., Intas Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., Mayne Pharma Group Limited, Midas Pharma GmbH, Mylan N.V, Novartis AG, Pfizer Inc., Skinvisible Pharmaceuticals, Inc., Stiefel Laboratories, Inc. by GSK Group, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Acne Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Acne Type, market is studied across Comedonal, Cystic, Inflammatory, and Postsurgical/Wound.
  • Based on Drug Class, market is studied across Antibiotics, Combination Drugs, Hormonal Agents, and Retinoids.
  • Based on Drug Type, market is studied across OTC Drugs and Prescription Drugs.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of skin-related diseases in individuals worldwide
      • 5.1.1.2. Growing awareness regarding skin health and inclination toward specific personalized treatments
      • 5.1.1.3. Increasing availability of acne drugs on eCommerce platforms
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of numerous alternatives for skin care drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of improved and enhanced acne drugs
      • 5.1.3.2. Emerging demand for combination therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and complicated processes in the approval of cosmetic drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acne Drugs Market, by Acne Type

  • 6.1. Introduction
  • 6.2. Comedonal
  • 6.3. Cystic
  • 6.4. Inflammatory
  • 6.5. Postsurgical/Wound

7. Acne Drugs Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Combination Drugs
  • 7.4. Hormonal Agents
  • 7.5. Retinoids

8. Acne Drugs Market, by Drug Type

  • 8.1. Introduction
  • 8.2. OTC Drugs
  • 8.3. Prescription Drugs

9. Acne Drugs Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Oral
  • 9.4. Topical

10. Americas Acne Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Acne Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Acne Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Almirall, S.A.
  • 3. Amgen, Inc.
  • 4. Apotex Inc.
  • 5. Arctic Therapeutics
  • 6. Bausch Health Companies Inc.
  • 7. Bayer AG
  • 8. BioPharmX, Inc.
  • 9. Cipher Pharmaceuticals Inc.
  • 10. Daiichi Sankyo Company, Ltd.
  • 11. Dr. Reddy's Laboratories Ltd.
  • 12. F. Hoffmann-La Roche AG
  • 13. Galderma S.A.
  • 14. Intas Pharmaceuticals Ltd.
  • 15. Johnson & Johnson Services, Inc.
  • 16. Mayne Pharma Group Limited
  • 17. Midas Pharma GmbH
  • 18. Mylan N.V
  • 19. Novartis AG
  • 20. Pfizer Inc.
  • 21. Skinvisible Pharmaceuticals, Inc.
  • 22. Stiefel Laboratories, Inc. by GSK Group
  • 23. Sun Pharmaceutical Industries Limited
  • 24. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ACNE DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ACNE DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACNE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ACNE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ACNE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACNE DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACNE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACNE DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACNE DRUGS MARKET SIZE, BY COMEDONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACNE DRUGS MARKET SIZE, BY CYSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ACNE DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ACNE DRUGS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACNE DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ACNE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACNE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. ACNE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. ACNE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023